Related Experiment Video
Updated: Aug 15, 2026

Enhanced Reduced Representation Bisulfite Sequencing for Assessment of DNA Methylation at Base Pair Resolution
Published on: February 24, 2015
[DNA Methylation as a Biomarker for Chromatinopathies: Present and Future]
O A Zemlianaia1,2, A V Efremova1, V V Strelnikov1
1Bochkov Research Center for Medical Genetics, Moscow, 115522 Russia.
DNA methylation patterns, or episignatures, are emerging biomarkers for diagnosing over 70 hereditary chromatinopathies. Analyzing these epigenetic changes enhances diagnostic accuracy for rare genetic disorders.
Area of Science:
- Genetics
- Epigenetics
- Molecular Biology
Background:
- Massively parallel sequencing has advanced hereditary disease diagnostics.
- However, improving detection rates for specific genetic disorders remains a challenge.
- DNA methylation is increasingly recognized as a biomarker for pathological conditions, particularly epigenetic machinery damage.
Purpose of the Study:
- To explore DNA methylation patterns (episignatures) as diagnostic biomarkers for chromatinopathies.
- To review the molecular basis, identification principles, and applications of these epigenetic markers.
- To discuss the potential and limitations of DNA methylation analysis in diagnosing hereditary diseases.
Main Methods:
- Review of scientific literature on DNA methylation and chromatinopathies.
- Analysis of identified "episignatures" for over 70 syndromes.
- Examination of diagnostic methodologies and their effectiveness.
Main Results:
- Specific DNA methylation patterns (episignatures) are linked to over 70 chromatinopathies.
- Episignatures significantly improve the differential diagnosis of these hereditary syndromes.
- DNA methylation analysis offers a promising avenue for optimizing chromatinopathy diagnosis.
Conclusions:
- DNA methylation patterns serve as reliable biomarkers for diagnosing a wide range of chromatinopathies.
- The analysis of episignatures represents a significant advancement in the molecular genetic diagnostics of hereditary diseases.
- Further development in DNA methylation analysis methods holds great potential for improving patient outcomes.
More Related Videos
13:21Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients
Published on: June 16, 2017
06:07Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
Published on: August 5, 2022
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Inheritance of Chromatin Structures
Spreading of Chromatin Modifications
Writers
The writer is an enzyme that can...
Chromatin Immunoprecipitation- ChIP
Types of ChIP
ChIP can be divided into two types - X-ChIP and N-ChIP. X-ChIP involves in vivo cross-linking of histones and regulatory proteins to DNA, fragmenting the DNA by sonication, and isolating the protein-DNA...
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...